PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROMES
Clinical trials for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROMES explained in plain language.
Never miss a new study
Get alerted when new PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROMES trials appear
Sign up with your email to follow new studies for PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROMES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Two-Step transplant shows promise for blood cancer patients
Disease control CompletedThis study tested a two-step stem cell transplant for people with blood cancers like leukemia and lymphoma. The approach uses low-dose chemo and radiation before a donor stem cell infusion, followed by drugs to prevent graft-versus-host disease. The goal was to control the cancer…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROMES
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 09:03 UTC
-
New drug combo shows promise for tough blood cancers
Disease control CompletedThis study tested a combination of two drugs, azacitidine and sirolimus, in 57 people with high-risk myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML) that had come back or was hard to treat. The goal was to see if the combination could stop cancer cells from growing…
Matched conditions: PREVIOUSLY TREATED MYELODYSPLASTIC SYNDROMES
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated May 26, 2026 08:34 UTC